Call for Abstract

6th Global Summit on Cancer, will be organized around the theme “”

Global Cancer 2022 is comprised of keynote and speakers sessions on latest cutting edge research designed to offer comprehensive global discussions that address current issues in Global Cancer 2022

Submit your abstract to any of the mentioned tracks.

Register now for the conference by choosing an appropriate package suitable to you.

Cancer terms an enormous spectrum of diseases that all instigate from uncontrolled cellular growth. Broadly allocated into benign tumors (unable to metastasize) or malignant tumors (able to invade normal tissues), cancers are further defined and classified by their cell type, tissue, or organ of origin. Cancer remains the number two cause of death in the U.S., second only to heart disease, and the Intramural Research Program (IRP) is dedicated to proceeding research, building expertise, and leveraging resources to address this global challenge. Our scientists are continually learning more about the sources of cancer, and emerging new and better ways to prevent, detect, and treat it.

Normal cells make up tissues, and when these cells lose their capability to behave as a specified, controlled and coordinated unit (dedifferentiation) the defect leads to disarray amongst the cell population. When this occurs, a tumor is formed. Cancer is a term recitation a large variety of disorders of proliferation. The specific disorder may differ from tissue type to tissue type. A single tumor may even have dissimilar populations of cells within it with differing procedures that have gone awry.


Cancer is instigated by changes (mutations) to the DNA within cells. The DNA inside a cell is wrapped into a large number of individual genes, each of which comprises a set of instructions telling the cell what functions to perform, as well as how to grow and divide. The aspects elaborate may be genetic, environmental, or constitutional characteristics of the individual.

Diagnosis, treatment, and prognosis for childhood cancers are dissimilar than for adult cancers. The main variances are the survival rate and the cause of the cancer. The overall five-year endurance rate for childhood cancer is about 80%, while in adult cancers the survival rate is 68%. This difference is thought to be because childhood cancer is more alert to therapy and a child can tolerate more aggressive therapy.


An imaging assessment is a way to let doctors see what’s going on inside your body. These investigations send forms of energy (like x-rays, sound waves, radioactive particles, or magnetic fields) through your body. Your body tissues change the energy outlines to make an image or picture. These pictures show how your insides look and work so that health care providers can see variations that may be caused by diseases like cancer. Imaging tests are only fragment of cancer diagnosis and treatment. A comprehensive cancer work-up also contains talking about your medical history (asking questions about your symptoms and risk factors), a physical exam, and blood work or other lab tests. Many health care providers design x-rays or other imaging tests before treatment starts. These representations are then used to track changes during treatment. These are called baseline studies since they show how things detected at the start. They can be associated with later images to see the consequences of treatment over time.


Clinical trials for cancer are research studies that associate the most effective known treatment for a precise type or stage of cancer with a new approach. This can be a new drug, or mixture of drugs or a dissimilar way of using established therapies. There are trials that comprise new approaches to surgery and radiation therapy. There are clinical trials for all type of cancer. While many trials emphasis on late stage disease, there are also trials to prevent cancer, improve early diagnosis, stop the cancer from coming back, reduce side effects or improve quality of life.

The persistence of clinical trials is to find ways to more efficiently prevent, diagnose, or treat disease. Every drug and process that is used in cancer treatment was once studied as a part of a clinical trial.


Cancer treatment is the use of surgery, radiation, medications and other therapies to cure a cancer shrink a cancer or stop the development of a cancer. Many cancer treatments exist. Depending on your certain condition, you may receive one treatment or you may receive a combination of treatments. The aim of cancer treatment is to accomplish a cure for your cancer, allowing you to live a normal life span. This may or may not be probable, depending on your specific situation. If a cure isn't possible, your treatments may be used to shrink your cancer or deliberate the development of your cancer to allow you to live symptom free for as long as possible.


The epidemiology of cancer is the study of the features affecting cancer, as a way to assume possible trends and causes. The study of cancer epidemiology uses epidemiological methods to discover the source of cancer and to recognize and progress improved treatments.

This extent of study must resist with problems of lead time bias and length time bias. Lead time bias is the notion that early diagnosis may artificially inflate the survival statistics of a cancer, without really improving the usual history of the disease. Length bias is the concept that slower growing, more indolent tumors are more likely to be analyzed by screening tests, but improvements in diagnosing more cases of indolent cancer may not interpret into better patient outcomes after the implementation of screening programs.


Cancer has a complex Pathophysiology. Pathologists are physicians who are anxious primarily with the study of infection in all its aspects. This comprises cause of the disease, diagnosis, how the disease grows (pathogenesis), mechanism and natural course of the disease. They also deal with biochemical features, progression, and prognosis or consequence of the disease. Pathology of cancers and further complex disorders have undergone a alteration after expansion of technologies like immunohistochemistry, flow cytometry, and molecular biologic approaches to cancer diagnosis.


Prognosis of cancers frequently means the assessment of success with treatment and probabilities of recovery. The kind of cancer and where it is in your body. The stage of the cancer, which states to the size of the cancer and if it has spread to other parts of your body. The cancer's grade, which states to how irregular the cancer cells look under a microscope. Many factors can impact the prognosis of a person with cancer. Among the most important are the type and site of the cancer, the stage of the disease (the extent to which the cancer has spread in the body), and the cancer’s grade (how abnormal the cancer cells look under a microscope—an indicator of how quickly the cancer is likely to grow and spread).


A cancer vaccine is a vaccine that either treats existing cancer or prevents development of cancer. Vaccines that treat current cancer are known as therapeutic cancer vaccines. Many of the vaccines are "autologous", being prepared from samples taken from the patient, and are specific to that patient.

Some researcher’s privilege that cancerous cells routinely arise and are demolished by the immune system (immunosurveillance); and that tumors form when the immune system fails to abolish them. Some types of cancer, such as cervical cancer and liver cancer, are triggered by viruses (oncoviruses). Traditional vaccines against those viruses, such as the HPV vaccine and the hepatitis B vaccine, avoid those types of cancer. Other cancers are to some point caused by bacterial infections (e.g. stomach cancer and Helicobacter pylori). Traditional vaccines against cancer-causing bacteria (oncobacteria) are not further discussed in this article.


Nanotechnology has the potential to completely change how we analyze and treat cancer. Although scientists and engineers have only recently (ca. 1980's) developed the capability to industrialize technologies at this scale, there has been good development in translating Nano-based cancer therapies and diagnostics into the clinic and numerous more are in development.

Nanotechnology is the claim of materials, functionalized structures, devices, or systems at the atomic, molecular, or macromolecular scales. At these length scales, about the 1-100 nanometer range as defined by the U.S. National Nanotechnology Initiative (NNI) , exclusive and specific physical properties of matter exist, which can be eagerly manipulated for a desired application or effect. Furthermore, Nano scale structure can be used as individual entities or unified into larger material components, systems, and architectures.


MiRNAs might function as either oncogenes or tumor suppressors under assured conditions. The dysregulated MiRNAs have been shown to mark the hallmarks of cancer, including supporting proliferative signaling, evading growth suppressors, resisting cell death, activating invasion and metastasis, and inducing angiogenesis. MiRNA expression is tightly controlled by different transcription factors, so abnormal expression of MiRNA in cancer could be due to dysregulation of some key transcription factors, such as c-Myc and p53.


Breast cancer can arise in women and rarely in men. Breast cancer cells typically form a tumor that can often be seen on an x-ray or felt as a lump. Breast cancer occurs nearly entirely in women, but men can get breast cancer, too. It’s significant to understand that most breast lumps are benign and not cancer (malignant). Non-cancerous breast tumors are abnormal growths, but they do not extent outside of the breast. They are not life threatening, but some types of benign breast lumps can surge a woman's risk of getting breast cancer. Any breast lump or change needs to be patterned by a health care professional to regulate if it is benign or malignant (cancer) and if it might affect your future cancer risk.

Cervical cancer is a type of cancer that happens in the cells of the cervix — the lower part of the uterus that connects to the vagina. Various strains of the human papillomavirus (HPV), a sexually transmitted infection, play a part in causing most cervical cancer. When exposed to HPV, the body's immune system typically averts the virus from doing harm. In a small percentage of people, however, the virus endures for years, contributing to the process that grounds some cervical cells to become cancer cells.


Cancer screening tests are tests that look for the existence of cancer in healthy people or people without signs of cancer. Cancer screening tests are intended to find cancers at an early stage when they are more treatable Cancer screening helps find cancer initial before you have symptoms when it is easier to treat. Cancer screening helps find cancer before it spreads when it is easier to treat. Early finding may mean less treatment and less time spent recovering. The earlier a cancer is noticed, the better your chance of survival. There are some cancers which can really be screened and identified by simple tests and they are cancers of the breast, cervix, colon, prostate, lung, skin and oral cancers.

Depending on where the cancer is located, a physical exam may give some idea as to how much cancer there is. Imaging tests like x-rays, CT scans, MRIs, ultrasound, and PET scans may also give information about how much and where cancer is in the body. Effective diagnostic testing is used to confirm or eliminate the presence of disease, monitor the disease process, and to plan for and evaluate the effectiveness of treatment. In some cases, it is necessary to repeat testing when a person's condition has changed, if a sample collected was not of good quality, or an abnormal test result needs to be confirmed

  • Track 13-1Physical exam
  • Track 13-2Laboratory tests
  • Track 13-3Imaging tests
  • Track 13-4Biopsy